Medexus Pharmaceuticals (TSX:MDP) Treasury Stock : C$0.0 Mil (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Medexus Pharmaceuticals Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Medexus Pharmaceuticals's treasury stock for the quarter that ended in Dec. 2023 was C$0.0 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Medexus Pharmaceuticals Treasury Stock Historical Data

The historical data trend for Medexus Pharmaceuticals's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals Treasury Stock Chart

Medexus Pharmaceuticals Annual Data

Trend

Dec13

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Treasury Stock

Get a 7-Day Free Trial

Medexus Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Treasury Stock	Get a 7-Day Free Trial															-	-	-	-	-

Medexus Pharmaceuticals Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Medexus Pharmaceuticals (TSX:MDP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (TSX:MDP) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

MEDXF:USA P731:Germany

Address

35 Nixon Road, Suite 1, Bolton, ON, CAN, L7E 1K1

Website

https://www.medexus.com

Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company's focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.

Executives

Benoit Gravel

Director